Walgreens #7889 Durable Medical Equipment & Medical Supplies Location: 910 N Main St, Miami, Oklahoma 74354 Phone: (918) 540-9544 |
Regency Home Medical Equipment Durable Medical Equipment & Medical Supplies Location: 102 S Main St, Miami, Oklahoma 74354 Phone: (918) 542-9733 |
Osborn Drugs Long Term Care Pharmacy Location: 11 W Central Ave, Miami, Oklahoma 74354 Phone: (918) 542-4444 |
Walmart Pharmacy 10-0028 Durable Medical Equipment & Medical Supplies Location: 2415 N Main St, Miami, Oklahoma 74354 Phone: (918) 542-8429 |
Eye Assoc Of Miami Inc Medicare Supplier Location: 2222 N Main St, Miami, Oklahoma 74354 Phone: (918) 542-1929 |
John A Mcferron Od Inc Medicare Supplier Location: 16 2nd Ave Nw, Miami, Oklahoma 74354 Phone: (918) 542-2020 |
News Archive
Most of the political class seems to have decided that ObamaCare is working well enough, the opposition is fading, and the subsidies and regulation are settling in as the latest wing of the entitlement state.
The Massachusetts Commonwealth Health Insurance Connector, which is tasked under the state's new health insurance law with determining what premiums are affordable for low-income state residents, is proposing that the state's lower-income uninsured residents spend up to 6.6% of their income to purchase health coverage, the Boston Globe reports.
Peter Roy-Byrne, M.D., formerly of the University of Washington, Seattle, and colleagues write that few data exist on the effectiveness of brief (1-2 sessions) interventions for reducing problem drug use, a common issue in disadvantaged populations seeking care in safety-net medical settings (hospitals and community health clinics serving low-income patients with limited or no insurance).
The University of Michigan will join nine other clinical centers across the country working to compare the effectiveness of different treatment strategies for women with uterine fibroids.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today announced its financial results for the second quarter ended June 30, 2014 and provided a corporate update.
› Verified 3 days ago